Finding 1236137 (2024-002)

Material Weakness Repeat Finding
Requirement
B
Questioned Costs
-
Year
2024
Accepted
2026-09-23
Audit: 411767
Organization: Pop Biotechnologies Inc. (NY)

AI Summary

  • Core Issue: POP Biotechnologies Inc. failed to monitor subrecipients, lacking necessary procedures and documentation.
  • Impacted Requirements: This violates 2 CFR § 200.332(d), risking non-compliance with federal regulations and unmet performance goals.
  • Recommended Follow-Up: Establish formal monitoring procedures for subrecipients, ensuring proper documentation and compliance with Uniform Guidance.

Finding Text

Criteria: 2 CFR § 200.332(d) requires pass-through entities to monitor the activities of subrecipients as necessary to ensure that subawards are used for authorized purposes, in compliance with federal statutes, regulations, and the terms and conditions of the subaward, and that subaward performance goals are achieved[15]. Condition: For a selection of two subcontractors, POP Biotechnologies Inc. did not utilize a monitoring process for subrecipients. The organization did not create or maintain identifying information for all subrecipients, nor did it document monitoring activities. Cause: The organization has not developed or implemented formal subrecipient monitoring procedures, including the maintenance of required documentation. Effect or Potential Effect: Lack of subrecipient monitoring increases the risk that subawards may not be used for authorized purposes or in compliance with federal requirements, and that performance goals may not be achieved. Known Questioned Costs: None identified. Perspective Information: This deficiency was identified in both subrecipients selected for testing, suggesting a lack of systemic controls over subrecipient monitoring. Identification of Repeat Findings: This is a new finding for the current year. Recommendation: We recommend that POP Biotechnologies Inc. develop and implement formal subrecipient monitoring procedures, including maintaining identifying information for all subrecipients and documenting monitoring activities in accordance with Uniform Guidance requirements.

Corrective Action Plan

In 2025, POP Biotechnologies, Inc is implementing subrecipient monitoring process. POP Biotechnologies, Inc will create and maintain dedicated folders for subrecipients receiving greater than $75,000 in funding.

Categories

Subrecipient Monitoring

Other Findings in this Audit

  • 1236136 2024-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.395 CANCER TREATMENT RESEARCH $320,941
93.866 AGING RESEARCH $233,258
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $94,274
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $35,210